Literature DB >> 21083195

Pharmacokinetic applications of microdevices and microsampling techniques.

Florin Marcel Musteata1.   

Abstract

Pharmacokinetic studies require information regarding drug concentration at numerous time points during the process of absorption, distribution, metabolism and excretion. In order to obtain reproducible and good-quality data, the sampling method is as important as the bioanalytical method. A further difficulty in performing pharmacokinetic studies is related to the limited amount of sample that can be collected in some cases. Since analytical methods should interfere as little as possible with the investigated organism, microsampling techniques are a natural choice for pharmacokinetic studies. Accordingly, microdevices and microsampling approaches have been used increasingly in recent years for a wide variety of analytical applications, including analysis of drugs in biological samples. Such techniques not only reduce the amount of reagents needed for analysis, but are also faster and less disrupting. This review provides a brief overview of contemporary microsampling techniques: collection of small sample aliquots, ultrafiltration, microdialysis, solid-phase microextraction, biosensors and microfluidics. It is concluded that recent developments in microsampling and microdevices promise to streamline pharmacokinetic studies and bring bedside monitoring of therapeutic drugs into clinical practice.

Mesh:

Substances:

Year:  2009        PMID: 21083195     DOI: 10.4155/bio.09.18

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  4 in total

1.  Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic mice.

Authors:  Miho Nagayasu; Kazuhisa Ozeki
Journal:  Pharm Res       Date:  2021-03-29       Impact factor: 4.200

2.  Investigating transdermal delivery of vitamin D3.

Authors:  Ahmed Alsaqr; Mohammed Rasoully; Florin Marcel Musteata
Journal:  AAPS PharmSciTech       Date:  2015-01-22       Impact factor: 3.246

Review 3.  Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates.

Authors:  Miroslav Dostalek; Thomayant Prueksaritanont; Robert F Kelley
Journal:  MAbs       Date:  2017-05-02       Impact factor: 5.857

4.  Fit-for-Purpose Validation of a Ligand Binding Assay for Toxicokinetic Study Using Mouse Serial Sampling.

Authors:  Liang Zhu; Ying Wang; Alison Joyce; Ihor Djura; Boris Gorovits
Journal:  Pharm Res       Date:  2019-10-25       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.